RxDoctor Payments Data

Joseph Blas, MD

Vascular Surgery · Greenville, SCNPI 1730313313

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $62,017 of the $100,926 with a category attached, or 61.4%. 37 manufacturers reported payments, led by Johnson & Johnson at 53.6% of the total. 2025 is the largest year on record at $36,421, more than ten times the $2,816 reported in 2019. Among vascular surgery clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$100,926in general payments, 2019–2025

Across 549 payments — averaging $183.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$54K
  • Medical Device Business Services, Inc.$14K
  • Cook Incorporated$9K
  • W. L. Gore & Associates, Inc.$7K
  • Cook Medical LLC$4K
  • Inari Medical, Inc.$3K
  • plus $10K from 31 others
$234,168in research payments, 2019–2025

Across 44 payments — averaging $5321.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Laminate Medical Technologies Inc.$105K
  • Surmodics, Inc.$87K
  • Cook Research Incorporated$43K

What the payments were for

  • Consulting fees$62,01761%
  • Speaking & faculty fees$7,2507%
  • Travel & lodging$13,59013%
  • Food & beverage$18,01918%
  • Education$500%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$100,926 in reported general payments places this provider in the 90th percentile of 99 vascular surgery providers in South Carolina.

See all vascular surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$75,112
Medicare patients
248
Services billed
509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban22$12,534
ClopidogrelClopidogrel Bisulfate57$542
Cilostazol20$281

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →